Skip to main content
Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.05
-0.09 (-1.26%)
Apr 29, 2026, 4:08 PM HKT

HKG:1167 Revenue

In the year 2025, Jacobio Pharmaceuticals Group had annual revenue of 53.53M CNY, down -65.62%. Jacobio Pharmaceuticals Group had revenue of 7.86M in the half year ending December 31, 2025, a decrease of -66.09%.

Revenue
53.53M CNY
Revenue Growth
-65.62%
P/S Ratio
92.88
Revenue / Employee
273.09K CNY
Employees
196
Market Cap
5.53B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202553.53M-102.18M-65.62%
Dec 31, 2024155.71M92.19M145.13%
Dec 31, 202363.52M-32.23M-33.66%
Dec 31, 202295.75M-57.06M-37.34%
Dec 31, 2021152.81M-333.48M-68.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ocumension Therapeutics 895.09M
Laekna 118.76M
Guangzhou Innogen Pharmaceutical Group 146.34M
CK Life Sciences Int'l., (Holdings) 5.41B
Shandong Boan Biotechnology 873.36M
Qyuns Therapeutics 897.99M
Clover Biopharmaceuticals 3.90M
TYK Medicines 117.25K
Revenue Rankings

Jacobio Pharmaceuticals Group News

More News